Hemagen Diagnostics, Inc. (HMGN) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Hemagen Diagnostics, Inc. (HMGN).

Download OTCGems on Google Play Download OTCGems on the App Store

Equity Overview

Price & Market Data

Price: $0.0₃2

Daily Change: $0.00 / 0.00%

Daily Range: $0 - $0

Market Cap: $3,100

Daily Volume: 0

Details

Hemagen Diagnostics, Inc. provides human and veterinary diagnostic services worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its proprietary test kits are used to aid in the diagnosis of certain autoimmune and infectious diseases. It also provides human diagnostics, such as universal IFA components; supplies, controls and calibrators, accessories, and H-rotors; reagents, electrodes, equipment; and specialty assays, including Chagas, acute phase proteins, and cytokines. In addition, the company offers veterinary diagnostic products, such as equipment, reagents, supplies, accessories, and electrodes in chemistry, hematology, and electrolyte areas. Its products are used in laboratories, hospitals and blood banks. Hemagen Diagnostics, Inc. was incorporated in 1985 and is based in Columbia, Maryland.

Selected stocks

Playtech PLC (PYTCF)

Trend Micro Inc. (TMICY)

IL2M International Corp. (ILIM)